BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8733011)

  • 1. Interaction of the Ubc9 human homologue with c-Jun and with the glucocorticoid receptor.
    Göttlicher M; Heck S; Doucas V; Wade E; Kullmann M; Cato AC; Evans RM; Herrlich P
    Steroids; 1996 Apr; 61(4):257-62. PubMed ID: 8733011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occupancy and composition of proteins bound to the AP-1 sites in the glucocorticoid receptor and c-jun promoters after glucocorticoid treatment and in different cell types.
    Barrett TJ; Vedeckis WV
    Recept Signal Transduct; 1996; 6(3-4):179-93. PubMed ID: 9259052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9.
    Cho S; Kagan BL; Blackford JA; Szapary D; Simons SS
    Mol Endocrinol; 2005 Feb; 19(2):290-311. PubMed ID: 15539428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid receptor transcriptional activity determined by spacing of receptor and nonreceptor DNA sites.
    Pearce D; Matsui W; Miner JN; Yamamoto KR
    J Biol Chem; 1998 Nov; 273(46):30081-5. PubMed ID: 9804760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element.
    Uht RM; Anderson CM; Webb P; Kushner PJ
    Endocrinology; 1997 Jul; 138(7):2900-8. PubMed ID: 9202234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Composite glucocorticoid regulation at a functionally defined negative glucocorticoid response element of the human corticotropin-releasing hormone gene.
    Malkoski SP; Dorin RI
    Mol Endocrinol; 1999 Oct; 13(10):1629-44. PubMed ID: 10517666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transrepression of c-jun gene expression by the glucocorticoid receptor requires both AP-1 sites in the c-jun promoter.
    Wei P; Inamdar N; Vedeckis WV
    Mol Endocrinol; 1998 Sep; 12(9):1322-33. PubMed ID: 9731701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the glucocorticoid receptor gene by the AP-1 transcription factor.
    Wei P; Vedeckis WV
    Endocrine; 1997 Dec; 7(3):303-10. PubMed ID: 9657066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-protein interactions are implied in glucocorticoid receptor mutant 465*-mediated cell death.
    Chen H; Srinivasan G; Thompson EB
    J Biol Chem; 1997 Oct; 272(41):25873-80. PubMed ID: 9325319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of glucocorticoid-dependent growth inhibition in transformed mouse lung cells.
    Li J; Johnson TA; Hanson LA; Beer DG
    Mol Carcinog; 1996 Aug; 16(4):213-20. PubMed ID: 8784464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.
    Manna PR; Eubank DW; Stocco DM
    Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The glucocorticoid receptor synergizes with Jun homodimers to activate AP-1-regulated promoters lacking GR binding sites.
    Teurich S; Angel P
    Chem Senses; 1995 Apr; 20(2):251-5. PubMed ID: 7583019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-range electrostatic interactions influence the orientation of Fos-Jun binding at AP-1 sites.
    Ramirez-Carrozzi VR; Kerppola TK
    J Mol Biol; 2001 Jan; 305(3):411-27. PubMed ID: 11152600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma.
    Adcock IM; Lane SJ; Brown CR; Lee TH; Barnes PJ
    J Exp Med; 1995 Dec; 182(6):1951-8. PubMed ID: 7500041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(ADP-ribose) polymerase interacts with a novel human ubiquitin conjugating enzyme: hUbc9.
    Masson M; Menissier-de Murcia J; Mattei MG; de Murcia G; Niedergang CP
    Gene; 1997 May; 190(2):287-96. PubMed ID: 9197546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of functional inhibition of the glucocorticoid receptor by Fos/Jun.
    Touray M; Ryan F; Jaggi R; Martin F
    Oncogene; 1991 Jul; 6(7):1227-34. PubMed ID: 1650443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-specific bifunctional role of Jun oncogene family members on glucocorticoid receptor-dependent transcription.
    Maroder M; Farina AR; Vacca A; Felli MP; Meco D; Screpanti I; Frati L; Gulino A
    Mol Endocrinol; 1993 Apr; 7(4):570-84. PubMed ID: 8388998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-interacting protein 140 binds c-Jun and inhibits estradiol-induced activator protein-1 activity by reversing glucocorticoid receptor-interacting protein 1 effect.
    Teyssier C; Belguise K; Galtier F; Cavailles V; Chalbos D
    Mol Endocrinol; 2003 Feb; 17(2):287-99. PubMed ID: 12554755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential hormone-dependent transcriptional activation and -repression by naturally occurring human glucocorticoid receptor variants.
    de Lange P; Koper JW; Huizenga NA; Brinkmann AO; de Jong FH; Karl M; Chrousos GP; Lamberts SW
    Mol Endocrinol; 1997 Jul; 11(8):1156-64. PubMed ID: 9212062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism.
    McKay LI; Cidlowski JA
    Mol Endocrinol; 2000 Aug; 14(8):1222-34. PubMed ID: 10935546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.